ES2128567T3 - Metanoantracenos sustituidos con piperidinilo como antagonistas d1/d2 y antagonistas 5ht2 de la serotonina. - Google Patents

Metanoantracenos sustituidos con piperidinilo como antagonistas d1/d2 y antagonistas 5ht2 de la serotonina.

Info

Publication number
ES2128567T3
ES2128567T3 ES94919752T ES94919752T ES2128567T3 ES 2128567 T3 ES2128567 T3 ES 2128567T3 ES 94919752 T ES94919752 T ES 94919752T ES 94919752 T ES94919752 T ES 94919752T ES 2128567 T3 ES2128567 T3 ES 2128567T3
Authority
ES
Spain
Prior art keywords
sup
sub
chosen
alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94919752T
Other languages
English (en)
Inventor
Michael Thaddeus Klimas
Marc Ornal Terpko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ES2128567T3 publication Critical patent/ES2128567T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

NUEVOS COMPUESTOS DE PIPERIDINILO DE FORMULA (I) EN LA QUE X E Y SON INDEPENDIENTEMENTE ELEGIDOS ENTRE HIDROGENO, HALOGENO Y ALCOXI C1-6, R1 ES ELEGIDO ENTRE ANILLO HETEROARILO DE SEIS ELEMENTOS QUE CONTIENE DE 1 A 3 HETEROATOMOS ELEGIDOS ENTRE NITROGENO, OXIGENO Y AZUFRE Y SUS DERIVADOS BENZ, QUE PUEDE LLEVAR 1-2 SUSTITUYENTES ELEGIDOS ENTRE ALQUIL C1-6, HIDROXI, ALCOXI C1-6 QUE PUEDE LLEVAR UN GRUPO TRIFLUORMETILO, ALCOXICARBONILO C1-6, HIDROXIALQUIL C-6, BENCILOXI, HALO, ALQUILAMINOCARBONILO C-3, ARILO C1-3, AMINOCARBONILO QUE TIENE LA FORMULA : CONR{SUP,C}R{SUP,D} DONDE R{SUP,C} Y R{SUP,D} SON ELEGIDOS INDEPENDIENTEMENTE DE HIDROGENO, 2-PIRROLIDINILO, Y C16ALQUIL O DONDE R{SUP,C} Y R{SUP,D} JUNTO CON EL ATOMO DE NITROGENO AL QUE ESTAN ASOCIADO FORMAN UN NUCLEO HETEROCICLICO DE 6 ELEMENTOS EN EL QUE DICHO NITROGENO ES EL UNICO HETEROATOMO, R{SUP,E}S(O){SUB,N} R{SUP,F}HH Y R{SUP,G}S DONDE R{SUP,E} Y R{SUP,F} SON INDEPENDIENTEMENTE ELEGIDO ENTRE HIDROGENO Y ALQUILO C1-6 Y N ES O, Q E Y R{SUP,G} ES ELEGIDO ENTRE ALQUILCARBONILAMINOFENILO C{SUB,1-3} Y DI{(C{SUB,13})ALQUILAMINO{(C{SUB,1-6})ALQUILO, DONDE AL MENOS UNO DE LOS SUSTITUYENTES SOBRE EL NUCLEO HETEROARILO DE CINCO O SEIS ELEMENTOS ES UN SULFOXIDO QUIRAL DE LA FORMULA C{SUB,14}ALQUILSO, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, SON UTILES COMO ANTAGONISTAS DE DOPAMINA Y SON PARTICULARMENTE UTILES COMO AGENTES ANTISICOTICAS EN HUMANOS. LOS COMPUESTOS PUEDEN TAMBIEN SER UTILES EN OTROS TRASTORNOS NEUROLOGICOS Y PSIQUIATRICOS QUE INCLUIDO LA ESQUIZOFRENIA. TAMBIEN SE DESCRIBEN PROCESOS PARA PREPARAR LOS COMPUESTOS PIPERIDINILO ASI COMO SU USO EN MEDICINA.
ES94919752T 1993-07-09 1994-07-04 Metanoantracenos sustituidos con piperidinilo como antagonistas d1/d2 y antagonistas 5ht2 de la serotonina. Expired - Lifetime ES2128567T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314250A GB9314250D0 (en) 1993-07-09 1993-07-09 Piperidinyl compounds

Publications (1)

Publication Number Publication Date
ES2128567T3 true ES2128567T3 (es) 1999-05-16

Family

ID=10738563

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94919752T Expired - Lifetime ES2128567T3 (es) 1993-07-09 1994-07-04 Metanoantracenos sustituidos con piperidinilo como antagonistas d1/d2 y antagonistas 5ht2 de la serotonina.

Country Status (26)

Country Link
EP (1) EP0707579B1 (es)
JP (1) JP3031634B2 (es)
AP (1) AP521A (es)
AT (1) ATE175963T1 (es)
AU (1) AU687414B2 (es)
CA (1) CA2163994A1 (es)
CZ (1) CZ4496A3 (es)
DE (1) DE69416131T2 (es)
DK (1) DK0707579T3 (es)
DZ (1) DZ1796A1 (es)
ES (1) ES2128567T3 (es)
FI (1) FI960084A7 (es)
GB (2) GB9314250D0 (es)
HR (1) HRP940394A2 (es)
HU (1) HU219239B (es)
IL (1) IL110222A (es)
MY (1) MY111604A (es)
NO (1) NO960080L (es)
NZ (1) NZ268048A (es)
PL (1) PL312498A1 (es)
RU (1) RU2128178C1 (es)
SG (1) SG45425A1 (es)
SI (1) SI9400281A (es)
SK (1) SK2996A3 (es)
WO (1) WO1995001974A1 (es)
ZA (1) ZA944930B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9117639D0 (en) * 1991-08-15 1991-10-02 Ici Plc Therapeutic compounds

Also Published As

Publication number Publication date
PL312498A1 (en) 1996-04-29
DE69416131D1 (de) 1999-03-04
MY111604A (en) 2000-09-27
DE69416131T2 (de) 1999-06-10
ATE175963T1 (de) 1999-02-15
ZA944930B (en) 1995-01-16
HUT75116A (en) 1997-04-28
HRP940394A2 (en) 1996-12-31
DZ1796A1 (fr) 2002-02-17
FI960084A0 (fi) 1996-01-08
EP0707579A1 (en) 1996-04-24
CZ4496A3 (en) 1996-06-12
IL110222A (en) 1999-09-22
RU2128178C1 (ru) 1999-03-27
EP0707579B1 (en) 1999-01-20
NZ268048A (en) 1997-10-24
JP3031634B2 (ja) 2000-04-10
NO960080D0 (no) 1996-01-08
GB9314250D0 (en) 1993-08-18
JPH08512308A (ja) 1996-12-24
CA2163994A1 (en) 1995-01-19
HU219239B (en) 2001-03-28
SI9400281A (en) 1995-02-28
NO960080L (no) 1996-01-08
AU687414B2 (en) 1998-02-26
SG45425A1 (en) 1998-01-16
IL110222A0 (en) 1994-10-21
AP9400652A0 (en) 1994-07-31
DK0707579T3 (da) 1999-09-13
GB9413235D0 (en) 1994-08-24
FI960084A7 (fi) 1996-01-08
AP521A (en) 1996-08-05
HU9503554D0 (en) 1996-02-28
AU7077994A (en) 1995-02-06
WO1995001974A1 (en) 1995-01-19
SK2996A3 (en) 1997-02-05

Similar Documents

Publication Publication Date Title
ES2184772T3 (es) Derivados de bifenilo, procedimiento para su preparacion y su utilizacion como medicamentos.
MX9202027A (es) Compuestos de amina policiclicos y sus enantiomeros, metodo para su preparacion y composiciones farmaceuticas que los contienen.
AR017189A1 (es) Antagonistas del receptor de trombina triciclico sustituido, composicion farmaceutica que lo contiene y su uso para la manufactura de un medicamento
ES2123829T3 (es) Derivados de 3-(5-tetrazolil-bencil)amino-piperidina y antagonistas de las taquiquininas.
AR030189A1 (es) Compuesto de benzotiazol, uso del mismo para preparar una composicion farmaceutica y dicha composicion farmaceutica
KR930017900A (ko) 벤즈이미다졸릴 유도체, 이 화합물을 함유하는 약제학적 조성물 및 이의 제조방법
YU48854B (sh) Derivati n-(4-piperidinil) (dihidrobenzofuran ili dihidro-2h-benzopiran)karboksamida i postupak za njihovo dobijanje
PE20011081A1 (es) Derivados de piperazina y piperidina
ATE373656T1 (de) Azaindolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
ATE208779T1 (de) Substituierte spiroheterocyclische 1h-3-aryl- pyrrolidin-2,4-dion-derivate, verfahren zu deren herstellung und deren verwendung als schädlingsbekämpfungsmittel
SG47026A1 (en) Serotonin antagonists
PE20030653A1 (es) COMPUESTOS BICICLICOS[1,2,4]-TRIAZOL COMO ANTAGONISTAS DE RECEPTORES DE ADENOSINA A2a
AR004516A1 (es) Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen
ES8609303A1 (es) Un procedimiento para la preparacion de un derivado de acido6-fluor-1,4-dihidro-4-oxo-7-piperazinilquinolin sustituido-3-carboxilico
ES2110086T3 (es) Indoles sustituidos como antagonistas de la angiotensina ii.
ES2158126T3 (es) Quinoxalinadionas antagonistas del receptor nmda.
ES2099362T3 (es) Derivados de octahidrofenantreno.
AR027744A1 (es) Compuestos de eter difenilico utiles en terapia
ES2154470T3 (es) Derivados de tetrahidroisoquinolina y su uso farmaceutico.
ES2183866T3 (es) Derivados de beta-aril y beta-heteroaril-alfa-cianoacrilamidas sustituido como inhibidors de la tirosina quinasa.
ES2128567T3 (es) Metanoantracenos sustituidos con piperidinilo como antagonistas d1/d2 y antagonistas 5ht2 de la serotonina.
Żmudzki et al. Structure–5‐HT Receptor Affinity Relationship in a New Group of 7‐Arylpiperazynylalkyl and 7‐Tetrahydroisoquinolinylalkyl Derivatives of 8‐Amino‐1, 3‐dimethyl‐1H‐purine‐2, 6 (3H, 7H)‐dione
US5958945A (en) Naphthamide derivatives of 3-beta-amino azabicyclo octane or nonane as neuroleptic agents
AR002715A1 (es) Derivados de piperazina y piperazinona heterociclos substituidos particularmente utiles como antagonistas de los receptores de taquikinina,composicion farmaceutica que incluye uno de dichos derivados, uso de dichos compuestos en la preparacion de las composiciones y procedimiento para la preparacion de los derivados
AR058179A1 (es) Derivados de tiazolo[4,5-c]piridina. procesos de obtencion y composiciones farmaceuticas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 707579

Country of ref document: ES